Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Fischer Imaging and R2 Technology to Develop Breast Cancer Technology
Sep 2002
DENVER, Sept. 19 -- Fischer Imaging Corp. and R2 Technology Inc. announced they have signed a development and marketing agreement to customize CAD technology for use with Fischer's SenoScan Full Field Digital Mammography system.

R2's CAD technology is designed to assist radiologists in detection of breast cancer.

Under the agreement, Fischer Imaging will have sole worldwide distribution rights to its SenoScan Full Field Digital Mammography System integrated with R2's CAD technology. The combination of the two devices will require FDA approval for clinical use in the US, and the companies are each preparing the FDA premarket approval supplements to obtain clearance.

The R2 ImageChecker system was originally approved by the FDA in 1998 for use with film-based screening mammography to assist radiologists in minimizing false negative readings.

For more information, visit:

News & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.